{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:48:03Z","timestamp":1790920083780,"version":"4.1.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014840","name":"Gemeinsame Bundesausschuss","doi-asserted-by":"publisher","award":["01VSF18049"],"award-info":[{"award-number":["01VSF18049"]}],"id":[{"id":"10.13039\/501100014840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    is an opportunistic pathogen causing severe infections of the lung, burn wounds and eyes. Due to its intrinsic high antibiotic resistance the bacterium is difficult to eradicate. A promising therapeutic option is the use of\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    -specific bacteriophages. Thus, the implementation of a phage therapy requires their selection, production and systematic administration using multiple strains of the bacterial target. Here, we used 25 phages and tested their susceptibility on 141 different\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    strains isolated from patients with different types of infection. Comparative host spectrum analyses were carried out using double agar overlay plaque assay (DPA) and planktonic killing assay (PKA), which resulted in 70% of the cases in the same host range. All phages were assigned to known phage genera, but some of the phages are new species. Isolated members of the genera\n                    <jats:italic>Pakpunavirus<\/jats:italic>\n                    ,\n                    <jats:italic>Pbunavirus<\/jats:italic>\n                    (myoviruses),\n                    <jats:italic>Pawinskivirus<\/jats:italic>\n                    ,\n                    <jats:italic>Elvirus<\/jats:italic>\n                    (myoviruses, jumbo phages),\n                    <jats:italic>Litunavirus<\/jats:italic>\n                    and\n                    <jats:italic>Bruynoghevirus<\/jats:italic>\n                    (podoviruses) demonstrated great therapeutic potential due to strong lysis behavior on diverse strains. Seven phages were excluded for therapeutic purposes due to genetic determinants that confer lysogenicity. Due to automation with lower time expenditure in execution and analysis, PKA has the higher potential for implementation in diagnostics. Finally, different combinations of phages were tested\n                    <jats:italic>in silico<\/jats:italic>\n                    with various\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    strains. Highly efficient phage combinations eradicating multiple\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    strains were found. Thus, a solid basis for the development of a broad host range phage therapy was laid.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2025.1597009","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:19:14Z","timestamp":1747981154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Systematic bacteriophage selection for the lysis of multiple Pseudomonas aeruginosa strains"],"prefix":"10.3389","volume":"15","author":[{"given":"Finja","family":"Rieper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyke","family":"Bunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin","family":"Spr\u00f6er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"H\u00e4fner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Willy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"M\u00fcsken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Ziehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke H.E.","family":"Korf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"B1","volume-title":"Phage Cocktail Optimizer","author":"Abedon","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jtbi.2007.02.014","article-title":"Bacteriophage evolution given spatial constraint","volume":"248","author":"Abedon","year":"2007","journal-title":"J. Theor. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1071\/MA11090","article-title":"Bacteriophage taxonomy","volume":"32","author":"Ackermann","year":"2011","journal-title":"Microbiol. Aust."},{"key":"B4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000149758","article-title":"The present state of phage taxonomy","volume":"3","author":"Ackermann","year":"1974","journal-title":"Intervirology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12866-021-02197-z","article-title":"Sewage and sewage-contaminated environments are the most prominent sources to isolate phages against Pseudomonas aeruginosa","volume":"21","author":"Aghaee","year":"2021","journal-title":"BMC Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/v16071051","article-title":"Pseudomonas aeruginosa bacteriophages and their clinical applications","volume":"16","author":"Alipour-Khezri","year":"2024","journal-title":"Viruses"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/mra.00092-22","article-title":"Complete genome sequence of Pseudomonas aeruginosa bacteriophage PASA16, used in multiple phage therapy treatments globally","volume":"11","author":"Alkalay-Oren","year":"2022","journal-title":"Microbiol. Resour Announc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/aac.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12864-017-3729-z","article-title":"Three novel Pseudomonas phages isolated from composting provide insights into the evolution and diversity of tailed phages","volume":"18","author":"Amgarten","year":"2017","journal-title":"BMC Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12866-022-02603-0","article-title":"Antibacterial efficacy of lytic phages against multidrug-resistant Pseudomonas aeruginosa infections in bacteraemia mice models","volume":"22","author":"Arumugam","year":"2022","journal-title":"BMC Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"Aslam","year":"2019","journal-title":"Am. J. Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.drudis.2018.07.003","article-title":"Updates on the pathogenicity status of Pseudomonas aeruginosa","volume":"24","author":"Azam","year":"2019","journal-title":"Drug Discovery Today"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212527","article-title":"How to manage Pseudomonas aeruginosa infections","volume":"7","author":"Bassetti","year":"2018","journal-title":"Drugs Context"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/s41467-024-48675-6","article-title":"Prediction of Klebsiella phage-host specificity at the strain level","volume":"15","author":"Boeckaerts","year":"2024","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00953-20","article-title":"The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa","volume":"94","author":"Carballo-Ontiveros","year":"2020","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy\u2013history from Twort and d\u2019Herelle through Soviet experience to current approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/phage.2022.0016","article-title":"Professor Giorgi eliava and the eliava institute of bacteriophage","volume":"3","author":"Chanishvili","year":"2022","journal-title":"PHAGE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(98)09385-4","article-title":"Incidence of contact-lens-associated microbial keratitis\u00a0and its related morbidity","volume":"354","author":"Cheng","year":"1999","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111162","article-title":"Friends or foes? Rapid determination of dissimilar colistin and ciprofloxacin antagonism of Pseudomonas aeruginosa phages","volume":"14","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.21775\/cimb.040.081","article-title":"Phage therapy: the pharmacology of antibacterial viruses","volume":"40","author":"Danis-Wlodarczyk","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1086\/651135","article-title":"Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections","volume":"201","author":"Debarbieux","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B23","unstructured":"Breakpoint tables for interpretation of MICs and zone diameters: Version 12.0\n          \n          2022"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1038\/s41598-021-91456-0","article-title":"AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence","volume":"11","author":"Feldgarden","year":"2021","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.569159","article-title":"Case report: arthroscopic \u201cDebridement antibiotics and implant retention\u201d With local injection of personalized phage therapy to salvage a relapsing Pseudomonas aeruginosa prosthetic knee infection","volume":"8","author":"Ferry","year":"2021","journal-title":"Front. Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02573-17","article-title":"Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models","volume":"62","author":"Forti","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41564-024-01832-5","article-title":"Prediction of strain level phage-host interactions across the Escherichia genus using only genomic information","volume":"9","author":"Gaborieau","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-11-102","article-title":"Sequencing and characterization of Pseudomonas aeruginosa phage JG004","volume":"11","author":"Garbe","year":"2011","journal-title":"BMC Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41579-023-00934-x","article-title":"The highly diverse antiphage defence systems of bacteria","volume":"21","author":"Georjon","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"mBio"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.613529","article-title":"Analysis of selection methods to develop novel phage therapy cocktails against antimicrobial resistant clinical isolates of bacteria","volume":"12","author":"Haines","year":"2021","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204443","article-title":"Towards translation of PqsR inverse agonists: from in vitro efficacy optimization to in vivo proof-of-principle","volume":"10","author":"Hamed","year":"2023","journal-title":"Advanced Sci."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mra.00206-23","article-title":"Complete genome sequence of Pseudomonas aeruginosa phage UF_RH6, isolated from human lung","volume":"12","author":"Hashemi Shahraki","year":"2023","journal-title":"Microbiol. Resour Announc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"D482","DOI":"10.1093\/nar\/gkw1065","article-title":"Virus Variation Resource - improved response to emergent viral outbreaks","volume":"45","author":"Hatcher","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/jmm.0.001110","article-title":"Pseudomonas aeruginosa and microbial keratitis","volume":"69","author":"Hilliam","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B37","unstructured":"International Committee of Taxonomy of Viruses: Current Taxonomy Release\n          \n          2023"},{"key":"B38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.01015-21","article-title":"Diversity of Pseudomonas aeruginosa temperate phages","volume":"7","author":"Johnson","year":"2022","journal-title":"mSphere"},{"key":"B40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2020.01.005","article-title":"Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"22","author":"Kim","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/v11050454","article-title":"Still Something to Discover: Novel Insights into Escherichia coli Phage Diversity and Taxonomy","volume":"11","author":"Korf","year":"2019","journal-title":"Viruses"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.25646\/5916","article-title":"Erg\u00e4nzung zur Empfehlung der KRINKO \u201eHygienema\u00dfnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen St\u00e4bchen\u201d (2012) im Zusammenhang mit der von EUCAST neu definierten Kategorie \u201eI\u201d bei der Antibiotikaresistenzbestimmung: Konsequenzen f\u00fcr die Definition von MRGN","volume":"9","year":"2019","journal-title":"Epid Bull"},{"key":"B43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60327-164-6_7","article-title":"Enumeration of bacteriophages by double agar overlay plaque assay","volume":"501","author":"Kropinski","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.2147\/IDR.S318173","article-title":"Inhaled colistimethate sodium in the management of patients with bronchiectasis infected by Pseudomonas aeruginosa: A narrative review of current evidence","volume":"15","author":"La Rosa-Carrillo","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1002\/pmic.200800727","article-title":"Identification and comparative analysis of the structural proteomes of phiKZ and EL, two giant Pseudomonas aeruginosa bacteriophages","volume":"9","author":"Lecoutere","year":"2009","journal-title":"Proteomics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"D912","DOI":"10.1093\/nar\/gkab1107","article-title":"VFDB 2022: a general classification scheme for bacterial virulence factors","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3390\/v14122760","article-title":"In Vitro and Pre-Clinical Evaluation of Locally Isolated Phages, vB_Pae_SMP1 and vB_Pae_SMP5, Formulated as Hydrogels against Carbapenem-Resistant Pseudomonas aeruginosa","volume":"14","author":"Mabrouk","year":"2022","journal-title":"Viruses"},{"key":"B49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-021-01096-5","article-title":"Genome-driven elucidation of phage-host interplay and impact of phage resistance evolution on bacterial fitness","volume":"16","author":"Markwitz","year":"2021","journal-title":"ISME J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1099\/jmm.0.000778","article-title":"Forensic investigation into the origin of Pseudomonas aeruginosa PA14 - old but not lost","volume":"67","author":"Mathee","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1111\/1462-2920.14310","article-title":"Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers","volume":"20","author":"McCallin","year":"2018","journal-title":"Environ. Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1093\/bioinformatics\/btx440","article-title":"VICTOR: genome-based phylogeny and classification of prokaryotic viruses","volume":"33","author":"Meier-Kolthoff","year":"2017","journal-title":"Bioinformatics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.01263-20","article-title":"Genes influencing phage host range in Staphylococcus aureus on a species-wide scale","volume":"6","author":"Moller","year":"2021","journal-title":"mSphere"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00052-20","article-title":"Are there 1031 virus particles on earth, or more, or fewer","volume":"202","author":"Mushegian","year":"2020","journal-title":"J.\u00a0Bacteriol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/antibiotics11060734","article-title":"MDR pumps as crossroads of resistance: antibiotics and bacteriophages","volume":"11","author":"Nazarov","year":"2022","journal-title":"Antibiotics"},{"key":"B58","unstructured":"2023"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/v14071542","article-title":"An optimized checkerboard method for phage-antibiotic synergy detection","volume":"14","author":"Nikolic","year":"2022","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.medj.2023.07.002","article-title":"Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series","volume":"4","author":"Onallah","year":"2023","journal-title":"Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/S0140-6736(05)66759-1","article-title":"Georgia: an unlikely stronghold for bacteriophage therapy","volume":"365","author":"Parfitt","year":"2005","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00614-23","article-title":"Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing","volume":"61","author":"Parmar","year":"2023","journal-title":"J. Clin. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1067\/mcp.2000.109520","article-title":"Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals","volume":"68","author":"Payne","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/v15030739","article-title":"Characterization of virulent T4-like Acinetobacter baumannii bacteriophages DLP1 and DLP2","volume":"15","author":"Peters","year":"2023","journal-title":"Viruses"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1128\/JVI.00385-15","article-title":"Phage therapy: a step forward in the treatment of pseudomonas aeruginosa infections","volume":"89","author":"Pires","year":"2015","journal-title":"J. Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1093\/cid\/ciad481","article-title":"Magistral phage preparations: is this the model for everyone","volume":"77","author":"Pirnay","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1134\/S1022795408020051","article-title":"Study of the diversity in a group of phages of Pseudomonas aeruginosa species PB1 (Myoviridae) and their behavior in adsorbtion-resistant bacterial mutants","volume":"44","author":"Pleteneva","year":"2008","journal-title":"Russ J Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJM198909213211202","article-title":"The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses","volume":"321","author":"Poggio","year":"1989","journal-title":"N Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-016-0084-3","article-title":"Management of traumatic wounds in the Emergency Department: position paper from the Academy of Emergency Medicine and Care (AcEMC) and the World Society of Emergency Surgery (WSES)","volume":"11","author":"Prevaldi","year":"2016","journal-title":"World J. Emerg. Surg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/EBC20240012","article-title":"Phage diversity in one health","volume":"68","author":"Pye","year":"2024","journal-title":"Essays Biochem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1126\/science.7604262","article-title":"Common virulence factors for bacterial pathogenicity in plants and animals","volume":"268","author":"Rahme","year":"1995","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.2474","article-title":"2891. Nebulized phage therapy for patients with cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection: A phase 1b\/2a randomized, double-blind, placebo-controlled, multicenter study","volume":"10","author":"Rappo","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B75","first-page":"66","article-title":"Experimental phage therapy of burn wound infection: difficult first steps","volume":"4","author":"Rose","year":"2014","journal-title":"Int. J. Burns Trauma"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab385","article-title":"DeepHost: phage host prediction with convolutional neural network","volume":"23","author":"Ruohan","year":"2022","journal-title":"Brief Bioinform."},{"key":"B77","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1056\/NEJM198909213211201","article-title":"The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group","volume":"321","author":"Schein","year":"1989","journal-title":"N Engl. J. Med."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.590","article-title":"Synergy as a rationale for phage therapy using phage cocktails","volume":"2","author":"Schmerer","year":"2014","journal-title":"PeerJ"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1128\/AEM.00065-12","article-title":"High diversity and novel species of Pseudomonas aeruginosa bacteriophages","volume":"78","author":"Sep\u00falveda-Robles","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/14787210.2015.1023291","article-title":"Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus","volume":"13","author":"Serra","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-4-21","article-title":"Propagating the missing bacteriophages: a large bacteriophage in a new class","volume":"4","author":"Serwer","year":"2007","journal-title":"Virol. J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/v15030803","article-title":"Design of phage-cocktail-containing hydrogel for the treatment of Pseudomonas aeruginosa-infected wounds","volume":"15","author":"Shafigh Kheljan","year":"2023","journal-title":"Viruses"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00284-020-02011-5","article-title":"Characterization and Complete Genome Analysis of Pseudomonas aeruginosa Bacteriophage vB_PaeP_LP14 Belonging to Genus Litunavirus","volume":"77","author":"Shi","year":"2020","journal-title":"Curr. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microbiolres13010002","article-title":"The history and applications of phage therapy in Pseudomonas aeruginosa","volume":"13","author":"Silva","year":"2022","journal-title":"Microbiol. Res."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.116054","article-title":"Introducing \u201cRapid phage susceptibility testing\u201d (RPST): an accelerated lytic phage activity test for routine diagnostic laboratories within eight hours","volume":"107","author":"Skusa","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.201312-2142OC","article-title":"Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection","volume":"189","author":"Staudinger","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/antibiotics11020228","article-title":"Campylobacter bacteriophage cocktail design based on an advanced selection scheme","volume":"11","author":"Steffan","year":"2022","journal-title":"Antibiotics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/phage.2019.0001","article-title":"The virulence index: A metric for quantitative analysis of phage virulence","volume":"1","author":"Storms","year":"2020","journal-title":"PHAGE"},{"key":"B89","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijmm.2010.10.005","article-title":"Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections","volume":"301","author":"Tielen","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.01174-13","article-title":"Genome sequence of the small-colony variant Pseudomonas aeruginosa MH27, isolated from a chronic urethral catheter infection","volume":"2","author":"Tielen","year":"2014","journal-title":"Genome Announc"},{"key":"B92","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/v13030506","article-title":"A roadmap for genome-based phage taxonomy","volume":"13","author":"Turner","year":"2021","journal-title":"Viruses"},{"key":"B93","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/v8050116","article-title":"HostPhinder: A phage host prediction tool","volume":"8","author":"Villarroel","year":"2016","journal-title":"Viruses"},{"key":"B94","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"key":"B95","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/v15020588","article-title":"Phage therapy in Germany-update 2023","volume":"15","author":"Willy","year":"2023","journal-title":"Viruses"},{"key":"B96","volume-title":"World Health Organization: Bacterial Priority Pathogens List 2024 Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance","year":"2024"},{"key":"B97","doi-asserted-by":"publisher","first-page":"S337","DOI":"10.1093\/cid\/ciad514","article-title":"Towards standardization of phage susceptibility testing: the Israeli phage therapy center \u201cClinical phage microbiology\u201d-A pipeline proposal","volume":"77","author":"Yerushalmy","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00403","article-title":"Jumbo bacteriophages: an overview","volume":"8","author":"Yuan","year":"2017","journal-title":"Front. Microbiol."}],"updated-by":[{"DOI":"10.3389\/fcimb.2025.1650832","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000}}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1597009\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:40:20Z","timestamp":1755682820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1597009\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":98,"alternative-id":["10.3389\/fcimb.2025.1597009"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1597009","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"1597009"}}